Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Ireland specialist CIE Tours has expanded outside of Great Britain in recent years to destinations like Italy. Tours editor Brinley Hineman sat down with chief commercial officer Rosanne Zusman and ...

Since 1932, CIE Tours has been the premier tour operator for Ireland and Britain vacations, earning a reputation for excellence rooted in signature Irish hospitality. Its expertly crafted vacations to ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...